Reishi Beta-Glucans and Immune Cell Activation

Reishi (Ganoderma lucidum)

83.1% higher NK cell cytotoxic activity

In a 2023 randomized controlled trial of healthy adults, 84 days of reishi beta-glucan supplementation raised NK cell cytotoxic activity by 83.1% versus placebo, with a 19.5% rise in NK cell count and a 10% increase in serum IgA.

Chen et al., Foods, 2023

+19.5%

NK cell count increase at 84 days vs. placebo in healthy adults (Chen et al., Foods, 2023)

+10%

serum IgA increase in the same RCT, reflecting stronger mucosal immune defense

Dectin-1

the primary receptor on immune cells that recognizes and responds to reishi beta-glucans

Chen et al., Foods, 2023

View as image ↗

Reishi beta-glucans are the specific carbohydrate structures that make reishi mushroom immunologically active. In a 2023 randomized controlled trial published in Foods, healthy adults who took reishi beta-glucan for 84 days showed NK cell cytotoxic activity 83.1% higher than the placebo group. That is not a mechanistic hypothesis. It is a measured outcome in a controlled study. Understanding what reishi beta-glucans immune cells means in practice requires understanding what these molecules are and how they trigger a response.

For the science behind reishi as a whole, see What Is Reishi Mushroom? The Science Behind the Mushroom of Immortality.

What Makes Reishi Beta-Glucans Different from Oat Beta-Glucans

Every supplement label with "beta-glucan" listed as an ingredient is not talking about the same molecule. The beta-glucan category covers a family of carbohydrates with the same basic building block, glucose, arranged in very different configurations. That configuration determines what the molecule does in the body.

Oat beta-glucan, the kind found in oatmeal and oat fiber supplements, is a β-1,3;β-1,4-D-glucan. It forms a chain where glucose molecules are linked in two alternating patterns, creating a linear or slightly curved structure. This shape makes oat beta-glucan useful for cholesterol lowering: it forms a gel in the digestive tract that slows cholesterol absorption. The FDA has approved a health claim for oat beta-glucans and heart disease based on this mechanism.

Reishi beta-glucan is a β-1,3;β-1,6-D-glucan. The chain is primarily linked in one direction (β-1,3), with branches shooting off at regular intervals in a second direction (β-1,6). This creates a triple-helix structure in solution, with branches that project outward like a molecular bristle brush.

That branched structure is what matters for immune activation. The immune system's pattern recognition receptors for fungi are designed to detect exactly this kind of branched glucan structure. The branching signals "fungal cell wall" to immune cells, triggering a response. A linear glucan like oat beta-glucan fits those receptors poorly, because the branching pattern that the receptor is keyed to is absent.

This distinction has a practical consequence for supplement purchasing. A product labeled "high in beta-glucan" may be high in oat-derived beta-glucan, yeast beta-glucan, or mushroom beta-glucan. The immune effects documented in reishi research are specific to the β-1,3;β-1,6 structure. Listing beta-glucan content on a label without specifying the source and structural type does not indicate immune activity.^[2]

How Dectin-1 Triggers the Immune Activation Cascade

When a macrophage or NK cell encounters a fungal pathogen, it identifies the threat using surface detectors called pattern recognition receptors. Dectin-1 is one of these receptors, specifically designed to recognize the branched beta-glucan structure on fungal cell walls.

Reishi's beta-glucans present that same structure. When Dectin-1 on a macrophage binds to a reishi beta-glucan, it triggers a chain of internal signals inside the cell.^[2] The key signaling proteins involved are called Syk and CARD9. They relay the Dectin-1 signal to a master immune regulator called NF-kB. NF-kB activation switches on genes for cytokine production. Cytokines are the chemical signals immune cells use to communicate, coordinate, and escalate the response.

The result of this cascade: the macrophage becomes more aggressive at engulfing pathogens, releases cytokines that recruit other immune cells, and activates neighboring NK cells.

Reishi beta-glucans also bind two other receptors: CR3 (complement receptor 3) and TLR2 (toll-like receptor 2). Each receptor activates overlapping but distinct signaling pathways. TLR2 binding, for example, is particularly important for the dendritic cell activation that bridges the innate and adaptive immune responses.^[3]

Dendritic cells are the messengers between the immune system's two branches. The innate branch responds immediately and non-specifically to anything that looks foreign. The adaptive branch responds more slowly but with precision, creating targeted antibodies and T-cells against specific pathogens. Ganoderma polysaccharides activated human dendritic cells in cell culture research, upregulating the surface molecules that dendritic cells use to present information to T-cells and triggering cytokine patterns consistent with adaptive immune activation.^[7] For the full picture of how reishi connects innate and adaptive immunity, see How Reishi Modulates Innate and Adaptive Immunity.

The 2023 RCT: NK Cells, T-Cells, and IgA at 84 Days

Chen and colleagues ran a randomized controlled trial in healthy adult volunteers testing reishi beta-glucan supplementation against placebo over 84 days.^[1]

NK cells (natural killer cells) are the immune system's rapid-response assassins. They identify and destroy infected cells and abnormal cells without needing prior exposure to the specific threat. NK cell cytotoxic activity measures how effectively each NK cell kills its target when it encounters one.

The reishi beta-glucan group showed NK cell cytotoxic activity 83.1% higher than placebo at 84 days. The NK cell count itself was 19.5% higher. These are large improvements for a healthy population where immune function is not impaired at baseline.

The trial also measured T-lymphocyte subpopulations. T-lymphocytes are the adaptive immune system's specialized soldiers. CD3+ cells are all T-lymphocytes; CD4+ cells are helper T-cells that coordinate the immune response; CD8+ cells are cytotoxic T-cells that directly kill infected or abnormal cells. All three counts increased significantly in the reishi beta-glucan group.

The CD4/CD8 ratio reflects the balance between coordinating T-cells and killing T-cells. This ratio is used clinically as a marker of immune health. The ratio improved in the reishi group.

Finally, serum IgA rose by 10%. IgA is an antibody concentrated in the mucous membranes of the respiratory and digestive tracts, the main entry points for pathogens. Higher IgA levels reflect stronger mucosal immunity, the kind that matters most for preventing respiratory infections.

This is the most complete human immune activation dataset available for reishi beta-glucans, and it comes from healthy adults, not a diseased or immunocompromised population. The effects were consistent across multiple immune readouts simultaneously.

The Gut Route: How Beta-Glucans Also Work Through the Microbiome

Not all of the immune effects from orally consumed reishi beta-glucans come from direct receptor binding. Some work through a longer path.

Guo and colleagues gave Ganoderma polysaccharides to animals and tracked what happened in the gut and to the immune system.^[6] The beta-glucans changed the composition of the gut microbial community. Specifically, the populations of Bifidobacterium and Lactobacillus, two genera of bacteria associated with beneficial immune and metabolic effects, increased significantly.

Those bacteria then produced higher levels of short-chain fatty acids, small molecules made when gut bacteria ferment fiber. Short-chain fatty acids travel from the gut into the bloodstream. They interact with immune cells in the colon wall and in circulation, shifting those cells toward less inflammatory, more regulated behavior.

The result in the animal model was reduced colonic inflammation and reduced tumor formation, both outcomes driven by the immune cell changes that the short-chain fatty acids produced.

This gut-immune pathway means that reishi beta-glucans have at least two distinct routes to immune effect. One is direct: beta-glucan binds Dectin-1 on immune cells and activates them. The second is indirect: beta-glucan changes the gut microbial community, and the altered microbial community changes immune cell behavior throughout the body.

The gut pathway is entirely absent from consumer content about reishi immune effects. Most explanations focus solely on direct receptor binding. The indirect gut route helps explain why consistent daily supplementation over weeks (rather than a single dose) produces cumulative immune effects.

From Yogurt to Lab: Beta-Glucans Work in a Food Matrix Too

Consumer products increasingly incorporate reishi beta-glucans in food formats: functional beverages, enriched yogurts, and fortified foods. A question that follows is whether the beta-glucan retains its immune activity when embedded in a food matrix alongside other ingredients.

Henao and colleagues addressed this directly.^[5] They conducted a randomized controlled trial in children in Medellin, Colombia, using yogurt enriched with reishi beta-glucans. Children who consumed the enriched yogurt for 12 weeks showed significantly higher CD8+ cytotoxic T-cell counts and NK cell counts compared to the placebo group.

The yogurt matrix did not prevent the immune effects. The beta-glucan molecule survives the food context and retains its biological activity.

This is relevant for understanding what drives immune effects from mushroom consumption. The active molecule is the beta-glucan structure itself, not some property of the raw mushroom or a specific supplement formulation. Whether it arrives via a capsule, a food product, or potentially via cooking with reishi mushrooms, the Dectin-1 binding activity of the glucan chain is the key variable.

For a comparison of extraction methods and their effect on beta-glucan content, see Hot Water Extract vs. Dual Extract vs. Raw Powder: Which Delivers More Beta-Glucans?.

What the Systematic Review of Fungal Beta-Glucan Trials Concluded

Individual trials show effects in specific populations. A 2021 systematic review by Vlassopoulou and colleagues synthesized the evidence across RCTs of fungal beta-glucans more broadly, covering multiple mushroom species including Ganoderma.^[4]

The review found consistent improvements in immune cell counts and NK cell activity across the included trials. The effects were present in diverse populations. The strongest results appeared in immunocompromised subjects (cancer patients, people undergoing chemotherapy) and in the elderly, where immune function is reduced from the baseline level of healthy younger adults.

This pattern makes mechanistic sense. If beta-glucans work by bringing immune cell activity closer to an optimal state, the gains will be larger where there is more room for improvement. A healthy 25-year-old with vigorous NK cell activity may show smaller improvements than an elderly person whose NK cell function has declined with age.

The Chen 2023 RCT, which showed the 83.1% NK cytotoxic activity improvement in healthy adults, is an important counterpoint: even in people without immune compromise, the improvements were substantial. The baseline does not need to be low for the effect to be meaningful.

For what beta-glucans do beyond immune activation, including the emerging evidence on epigenetic reprogramming of immune cells, see How Beta-Glucans Epigenetically Reprogram Immune Cells. For reishi's immune effects during cancer treatment specifically, see Reishi for Immune Support During Chemotherapy. For the role of reishi triterpenes as the complement to beta-glucans, see How Reishi Triterpenes Differ from Polysaccharides in Mechanism.

The Bottom Line

Reishi beta-glucans are β-1,3;β-1,6-D-glucans that activate immune cells by binding Dectin-1, CR3, and TLR2 receptors. The structural distinction from oat beta-glucans explains why the immune effects are specific to mushroom-type beta-glucans. A 2023 RCT in healthy adults showed 83.1% higher NK cell cytotoxic activity, 19.5% higher NK cell count, and 10% higher IgA at 84 days. Beta-glucans also work through the gut microbiome as a second, indirect immune pathway.

Frequently Asked Questions

What are beta-glucans in reishi mushroom?

Reishi mushroom contains β-1,3;β-1,6-D-glucans, a class of sugar polymers built from glucose molecules linked in a branched pattern. The branching structure is what determines how beta-glucans interact with the immune system: it mimics the surface structure of fungal cell walls, triggering immune cells to recognize and respond to it via a receptor called Dectin-1. This is the class of beta-glucan responsible for reishi's immune-activating effects.

How do reishi beta-glucans activate immune cells?

Reishi beta-glucans bind to Dectin-1 receptors on the surface of macrophages and NK cells. This binding triggers an internal signaling cascade involving Syk and CARD9 proteins, which activates NF-kB, the master regulator of immune gene expression. The activated cell releases cytokines (chemical immune signals) and becomes more effective at killing pathogens. In a 2023 RCT, this process produced an 83.1% increase in NK cell cytotoxic activity versus placebo in healthy adults over 84 days.

What is Dectin-1 and why does it matter for reishi?

Dectin-1 is an immune cell receptor designed to detect the branched beta-glucan structure found on fungal cell walls. When Dectin-1 binds a beta-glucan, it triggers immune cell activation. Reishi's β-1,3;β-1,6-D-glucan structure fits Dectin-1 because it has the same branching pattern the receptor is tuned to detect. Oat beta-glucans (β-1,3;β-1,4) lack this branching and bind Dectin-1 poorly, which is why they produce cholesterol effects but not immune activation.

How much beta-glucan is in reishi mushroom?

Beta-glucan content varies significantly by reishi product type. Hot water extracts concentrated for polysaccharides typically contain higher beta-glucan levels than raw ground powder or alcohol-only extracts. The level on supplement labels is often listed as total polysaccharides rather than beta-glucans specifically. The Chen 2023 RCT used a standardized reishi beta-glucan supplement; the exact dose used was not specified in the brief data available here. Extraction method affects the final beta-glucan content significantly.

Do reishi beta-glucans work differently from oat beta-glucans?

Yes. They are structurally different molecules with different biological activities. Oat beta-glucan is β-1,3;β-1,4-linked, forming a mostly linear chain that creates a viscous gel in the gut, slowing cholesterol absorption. Reishi beta-glucan is β-1,3;β-1,6-linked, with branches that create a triple-helix structure that binds Dectin-1 immune receptors. Oat beta-glucans are well-evidenced for cholesterol lowering. Reishi beta-glucans are well-evidenced for immune cell activation. A supplement labeled "beta-glucan" without specifying source and structure type may be providing either, and the two are not interchangeable for immune purposes.

Sources & References

1. 1. Source details for this reference are not yet available.
2. 2. Source details for this reference are not yet available.
3. 3. Source details for this reference are not yet available.
4. 4. Source details for this reference are not yet available.
5. 5. Source details for this reference are not yet available.
6. 6. Source details for this reference are not yet available.
7. 7. Source details for this reference are not yet available.